CD137 ACTIVATION AUGMENTS THE EFFICACY OF EGFR-TARGETED THERAPY

被引：0
|
作者：
不详
机构：
来源：
CANCER DISCOVERY | 2014年 / 4卷 / 07期
关键词：
D O I：
10.1158/2159-8290.CD-RW2014-120
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Major finding: Treatment with anti-CD137 mAb improves cetuximab efficacy by enhancing immune responses. Mechanism: Cetuximab induces CD137 on NK cells, and CD137 targeting stimulates ADCC and adaptive immunity. Impact: Dual antibody therapy may be beneficial in EGFR-positive cancers, including KRAS-mutant tumors. © 2014 American Association for Cancer Research.
引用
收藏
页码：758 / 758
页数：1
相关论文
共 50 条
  • [1] EGFR-targeted therapy
    Vecchione, Loredana
    Jacob, Bart
    Normanno, Nicola
    Ciardiello, Fortunato
    Tejpar, Sabine
    EXPERIMENTAL CELL RESEARCH, 2011, 317 (19) : 2765 - 2771
  • [2] EGFR-Targeted Photodynamic Therapy
    Ulfo, Luca
    Costantini, Paolo Emidio
    Di Giosia, Matteo
    Danielli, Alberto
    Calvaresi, Matteo
    PHARMACEUTICS, 2022, 14 (02)
  • [3] EGFR-TARGETED THERAPY AND RESISTANCE
    Hasovits, Csilla
    Pavlakis, Nick
    CANCER FORUM, 2013, 37 (02) : 165 - 169
  • [4] Activation of CD137 using multivalent and tumor targeted Bicyclic peptides
    Hurov, Kristen E.
    Upadhyaya, Punit
    Kublin, Jessica
    Zhou, Xueyuan
    Kristensson, Julia
    Lani, Rachid
    Mudd, Gemma
    van Rietschoten, Katerine
    An, Frank
    Lahdenranta, Johanna
    Chen, Liuhong
    Bennett, Gavin
    McDonnell, Kevin
    Park, Peter
    Keen, Nicholas
    CANCER RESEARCH, 2019, 79 (13)
  • [5] Current perspectives in EGFR-targeted therapy
    不详
    MEMO-MAGAZINE OF EUROPEAN MEDICAL ONCOLOGY, 2019, 12 : S32 - S34
  • [6] Activation of the AXL kinase causes resistance to EGFR-targeted therapy in lung cancer
    Zhang, Zhenfeng
    Lee, Jae Cheol
    Lin, Luping
    Olivas, Victor
    Au, Valerie
    LaFramboise, Thomas
    Abdel-Rahman, Mohamed
    Wang, Xiaoqi
    Levine, Alan D.
    Rho, Jin Kyung
    Choi, Yun Jung
    Choi, Chang-Min
    Kim, Sang-We
    Jang, Se Jin
    Park, Young Soo
    Kim, Woo Sung
    Lee, Dae Ho
    Lee, Jung-Shin
    Miller, Vincent A.
    Arcila, Maria
    Ladanyi, Marc
    Moonsamy, Philicia
    Sawyers, Charles
    Boggon, Titus J.
    Ma, Patrick C.
    Costa, Carlota
    Taron, Miquel
    Rosell, Rafael
    Halmos, Balazs
    Bivona, Trever G.
    NATURE GENETICS, 2012, 44 (08) : 852 - +
  • [7] Resistance to EGFR-Targeted Therapy: A Family Affair
    Vlacich, Gregory
    Coffey, Robert J.
    CANCER CELL, 2011, 20 (04) : 423 - 425
  • [8] Activation of the AXL kinase causes resistance to EGFR-targeted therapy in lung cancer
    Zhenfeng Zhang
    Jae Cheol Lee
    Luping Lin
    Victor Olivas
    Valerie Au
    Thomas LaFramboise
    Mohamed Abdel-Rahman
    Xiaoqi Wang
    Alan D Levine
    Jin Kyung Rho
    Yun Jung Choi
    Chang-Min Choi
    Sang-We Kim
    Se Jin Jang
    Young Soo Park
    Woo Sung Kim
    Dae Ho Lee
    Jung-Shin Lee
    Vincent A Miller
    Maria Arcila
    Marc Ladanyi
    Philicia Moonsamy
    Charles Sawyers
    Titus J Boggon
    Patrick C Ma
    Carlota Costa
    Miquel Taron
    Rafael Rosell
    Balazs Halmos
    Trever G Bivona
    Nature Genetics, 2012, 44 : 852 - 860
  • [9] CD137, implications in immunity and potential for therapy
    Thum, Elaine
    Zhe, Shao
    Schwarz, Herbert
    FRONTIERS IN BIOSCIENCE-LANDMARK, 2009, 14 : 4173 - 4188
  • [10] EVALUATION OF EFFICACY AND TOXICITY OF CD137 IMMUNOTHERAPY WITH URELUMAB-MIGG1 CHIMERIC ANTIBODY IN CD137 HUGEMM™
    Zhang, Hongjuan
    He, Daniel
    Zhang, Mingkun
    Feng, Xinhe
    An, Annie
    Ju, Cunxiang
    Li, Henry
    Ouyang, Davy
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2020, 8 : A388 - A388
12345